Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-first-subject-dosed-in-its-first-in-human-clinical-trial-of-fp-020-302131320.html
https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-poster-presentation-and-participation-at-the-2024-american-thoracic-society-international-conference-302129816.html
https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-receives-positive-recommendation-from-dsmb-to-continue-the-casppian-study-a-phase-3-clinical-trial-of-leuprolide-fp-001-injectable-emulsion-for-the-treatment-of-central-precocious-puberty-302104381.html
https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-publication-of-preclinical-data-in-the-european-heart-journal-demonstrating-the-therapeutic-potential-of-foresee-aldh2-activators-in-the-treatment-of-heart-failure-and-further-elucidating-a-novel--301981649.html
https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-to-present-at-the-american-heart-association-annual-meeting-focusing-on-its-aldh2-activator-fp-045-in-pulmonary-hypertension-associated-with-interstitial-lung-disease-301971135.html
https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-first-patient-dosed-in-the-casppian-phase-3-clinical-trial-of-leuprolide-fp-001-injectable-emulsion-42-mg-for-the-treatment-of-central-precocious-puberty-patients-301955873.html
https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-to-present-phase-12-fanconi-anemia-clinical-study-design-for-its-aldh2-activator-fp-045-at-the-fanconi-anemia-research-fund-2023-scientific-symposium-301943655.html
https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-publication-of-preclinical-data-in-nature-communications-demonstrating-the-therapeutic-potential-of-aldh2-activator-ad-9308-in-the-treatment-of-obesity-and-metabolic-syndrome-related-disorders-301943193.html
https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-presents-data-from-its-aderamastat-program-at-the-european-respiratory-society-ers-international-congress-2023-301923971.html
https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-fda-orange-book-listing-of-new-us-patent-for-camcevi-extending-patent-protection-to-2039-301912712.html